Evidence map›Paper›PMID 39459844›Full record

ArticleViruses2024

Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis.

Bryant Avalos, Jacqueline R Kulbe, Mary K Ford, Anna Elizabeth Laird, Kyle Walter, Michael Mante, Jazmin B Florio, Ali Boustani, Antoine Chaillon, Johannes C M Schlachetzki and 7 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bryant AvalosDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0000-0002-1863-2060
Jacqueline R KulbeDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.
Mary K FordDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.
Anna Elizabeth LairdDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.
Kyle WalterDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0009-0004-0323-8222
Michael ManteAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, 9880 Mesa Rim Road, San Diego, CA 92121, USA.
Jazmin B FlorioAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, 9880 Mesa Rim Road, San Diego, CA 92121, USA.
Ali BoustaniDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0000-0001-8146-7574
Antoine ChaillonDepartment of Medicine, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0000-0001-9490-3857
Johannes C M SchlachetzkiDepartment of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0000-0002-7801-9743
Erin E SundermannDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0000-0001-5821-8035
David J VolskyDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Robert A RissmanAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, 9880 Mesa Rim Road, San Diego, CA 92121, USA.
Ronald J EllisDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.ORCID 0000-0003-4931-752X
Scott L LetendreDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.
Jennifer IudicelloDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.
Jerel Adam FieldsDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAMES B BREWER · 2019 to 2026
$34.9M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Hussein N Yassine · 2020 to 2026
$27.8M
Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIVR01DA058405 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jerel Adam Fields, Jennifer E Iudicello · 2023 to 2026
$5.0M
Training in Research on Addictions in Interdisciplinary NeuroAIDS (TRAIN)T32DA031098 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello, DAVID J MOORE · 2011 to 2026
$4.6M
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent MiceR01DA052844 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BORJABAD, ALEJANDRA, KELSCHENBACH, JENNIFER L · 2020 to 2024
$3.6M
Cannabis, inflammation, and the brain in persons with HIVR01DA053052 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IUDICELLO, JENNIFER E · 2020 to 2024
$3.2M
Applying Hypertension Clinical Trials to Real World Adults with CKDR01DK128108 · NIDDK · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI KURELLA TAMURA, MANJULA · 2021 to 2025
$3.2M
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brainR01MH128108 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jerel Adam Fields · 2022 to 2026
$2.3M
The role of TREM2 in Alzheimer's disease neuropathogenesis in HIV+ individualsR56AG066215 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIELDS, JEREL ADAM · 2020 to 2020
$749k
NIAID NIH HHS P30 AI036214NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066530NIA NIH HHS R56 AG066215NIDA NIH HHS R01053052NIDA NIH HHS R01 DA052844NIDA NIH HHS R01 DA053052NIDA NIH HHS R01 DA058405NIDA NIH HHS T32 DA031098NIDDK NIH HHS R01 DK128108NIMH NIH HHS R01 MH128108
6 · The paper itself

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) is involved in neuroinflammation and HIV-associated neurocognitive impairment (NCI). People with HIV (PWH) using cannabis exhibit lower inflammation and neurological disorders. We hypothesized that TREM2 dysfunction mediates HIV neuropathogenesis and can be reversed by cannabinoids. EcoHIV-infected wildtype (WT) and TREM2

Indexed as

CannabidiolHIV InfectionsMembrane GlycoproteinsReceptors, ImmunologicAnimalsCannabisFemaleHumansMacrophagesMaleMiceCannabidiolMembrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanTrem2 protein, mousecannabisCBDHIVimmunomodulatoryneuroinflammationTREM2

Identifiers

PMID39459844
PMCPMC11512329

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.